Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Female Uniform Single Dose TA Patient	13
Overall Study	STARTED	Female Weighted Dose TA Patient	12
Overall Study	STARTED	Control	25
Overall Study	STARTED	Male Uniform Single Dose TA Patient	7
Overall Study	STARTED	Male Weighted Dose TA Patient	8
Overall Study	COMPLETED	Female Uniform Single Dose TA Patient	13
Overall Study	COMPLETED	Female Weighted Dose TA Patient	12
Overall Study	COMPLETED	Control	25
Overall Study	COMPLETED	Male Uniform Single Dose TA Patient	7
Overall Study	COMPLETED	Male Weighted Dose TA Patient	8
Overall Study	NOT COMPLETED	Female Uniform Single Dose TA Patient	0
Overall Study	NOT COMPLETED	Female Weighted Dose TA Patient	0
Overall Study	NOT COMPLETED	Control	0
Overall Study	NOT COMPLETED	Male Uniform Single Dose TA Patient	0
Overall Study	NOT COMPLETED	Male Weighted Dose TA Patient	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01651806/flow